Charles F. Wagner Jr., EVP, CO and FO of Vertex Pharmaceuticals ($VRTX), sold about $10.8 million in company shares across three open market transactions over the last year. His most recent sale occurred on January 6, 2026. These sales rank him 1,065th among nearly 12,000 insiders by total value sold, above the average of $8.6 million per insider and 6.4 transactions. Wagner made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 1744 | $485.11 | 47,042.0000 | 258,000,000 | 3.57% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 2294 | $483.75 | 48,786.0000 | 258,000,000 | 4.49% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 7365 | $0.00 | 51,080.0000 | 258,000,000 | 16.85% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 4565 | $487.76 | 43,715.0000 | 258,000,000 | 9.46% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 3045 | $468.41 | 48,280.0000 | 258,000,000 | 5.93% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 4160 | $0.00 | 51,325.0000 | 258,000,000 | 8.82% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 9440 | $0.00 | 47,165.0000 | 258,000,000 | 25.02% | 0.00% |
| Jan. 6, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | M | Stock Option (Right to Buy) | 9532 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.00% |
| Jan. 6, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | M | Common Stock | 9532 | $189.38 | 47,257.0000 | 258,000,000 | 25.27% | 0.00% |
| Jan. 6, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 9532 | $461.00 | 37,725.0000 | 258,000,000 | 20.17% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 7000 | $461.00 | 37,725.0000 | 258,600,000 | 15.65% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 7000 | $451.00 | 44,725.0000 | 258,600,000 | 13.53% | 0.00% |
| June 10, 2025 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 793 | $0.00 | 2,468.6500 | 1,119,333,622 | 47.36% | 0.00% |
| June 10, 2025 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 21 | $0.00 | 2,489.2500 | 1,119,333,622 | 0.83% | 0.00% |
| June 10, 2025 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 793 | $0.00 | 2,468.6500 | 1,119,333,622 | 47.36% | 0.00% |
| June 10, 2025 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 21 | $0.00 | 2,489.2500 | 1,119,333,622 | 0.83% | 0.00% |
| March 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3298 | $500.00 | 51,671.0000 | 257,899,999 | 6.00% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 4962 | $479.61 | 54,969.0000 | 257,899,999 | 8.28% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3310 | $483.28 | 59,931.0000 | 257,899,999 | 5.23% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2293 | $463.46 | 63,241.0000 | 257,899,999 | 3.50% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 6655 | $0.00 | 65,534.0000 | 257,899,999 | 11.30% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2649 | $467.98 | 58,879.0000 | 257,899,999 | 4.31% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 10262 | $0.00 | 54,414.0000 | 257,899,999 | 23.24% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 7114 | $0.00 | 61,528.0000 | 257,899,999 | 13.07% | 0.00% |
| Nov. 11, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3000 | $518.27 | 44,137.0000 | 261,000,000 | 6.36% | 0.00% |
| June 4, 2024 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 945 | $0.00 | 1,665.9000 | 1,134,000,000 | 130.94% | 0.00% |
| June 4, 2024 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 9 | $0.00 | 1,675.2500 | 1,134,000,000 | 0.56% | 0.00% |
| June 4, 2024 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 945 | $0.00 | 1,665.9000 | 1,134,000,000 | 130.94% | 0.00% |
| June 4, 2024 | TJX COMPANIES INC /DE/ | $TJX | WAGNER CHARLES F JR | Not found | A | Deferred Stock Units | 9 | $0.00 | 1,675.2500 | 1,134,000,000 | 0.56% | 0.00% |
| June 3, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3250 | $460.00 | 47,137.0000 | 260,500,000 | 6.45% | 0.00% |
| May 28, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3250 | $454.79 | 50,387.0000 | 260,500,000 | 6.06% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3309 | $431.79 | 53,583.0000 | 260,500,000 | 5.82% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2812 | $420.58 | 56,892.0000 | 260,500,000 | 4.71% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3750 | $424.01 | 59,704.0000 | 260,500,000 | 5.91% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2607 | $422.74 | 63,454.0000 | 260,500,000 | 3.95% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 7114 | $0.00 | 66,061.0000 | 260,500,000 | 12.07% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 5814 | $0.00 | 49,507.0000 | 260,500,000 | 13.31% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 9440 | $0.00 | 58,947.0000 | 260,500,000 | 19.07% | 0.00% |
| Jan. 2, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3000 | $405.00 | 43,693.0000 | 260,500,000 | 6.42% | 0.00% |